Glaxo Wellcome Inc. et al. v. Canada (Minister of National Health and Welfare) and Apotex Inc., (1997) 134 F.T.R. 220 (TD)
Linked as:
Extract
Glaxo Wellcome Inc. et al. v. Canada (Minister of National Health and Welfare) and Apotex Inc., (1997) 134 F.T.R. 220 (TD)
No longer available (Autolink)
See the full content of this document
This document cites
- Deprenyl Research Ltd. et al. v. Apotex Inc. et al., (1994) 77 F.T.R. 62 (TD)
- Eli Lilly & Co. et al. v. Novopharm Ltd. et al., (1995) 95 F.T.R. 96 (TD)
- Eli Lilly & Co. et al. v. Apotex Inc. et al., (1996) 195 N.R. 378 (FCA)
- Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare), (1997) 126 F.T.R. 209 (TD)
- Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1995) 106 F.T.R. 294 (TD)
